2013-58-3C=C1c2c(Cl)ccc(O)c2C(O)=C2C(=O)[C@]3(O)C(O)=C(C(N)=O)C(=O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12RNIADBXQDMCFEN-IWVLMIASSA-NMeclocycline is a member of tetracyclines.
2013-58-3DTXSID4048567CHEMBL1237124CHEBI:135772Pharmaceuticals -> Listed in ZINC15
Pharmaceuticals -> Antibiotics
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
As a tetracycline, meclocycline likely works by reversably associating with the 30s subint of the bacterial ribosome. A likely binding site for tetracyclines has been identified on protein S7 of this subunit. This association blocks the association of aminoacyl-tRNA with the ribosome, inhibiting protein synthesis. Ultimately this inhibits bacterial growth due to a lack of proteins necessary for reproduction.
Estimated oral bioavailability of ~66% and tmax of 4h based on that of demeclocycline due to structural similarity.
Estimated urinary excretion of ~40% and fecal excretion of ~43% based on that of demeclocycline due to structural similarity.
Estimated Vd of 121L based on that of demeclocycline due to structural similarity.
용도Meclocycline is a semi-synthetic tetracycline prepared by dehydration of the 6-hydroxy group of chlortetracycline to yield an exocyclic 6-methylene. Meclocyline is a close structural analogue of methacycline. Like all tetracyclines, meclocycline shows broad spectrum antibacterial and antiprotozoan activity and acts by binding to the 30S and 50S ribosomal sub-units, blocking protein synthesis. Meclocycline has been extensively cited in the literature with over 400 references.